tiprankstipranks
5 Top Small-Cap Stocks to Buy Now, According to Analysts – October 2023
Stock Analysis & Ideas

5 Top Small-Cap Stocks to Buy Now, According to Analysts – October 2023

Story Highlights

Small-cap stocks have the potential to grow at a faster rate compared to their larger peers but are often overlooked by investors. Using TipRanks’ Stock Screener tool, we have shortlisted five such stocks with significant upside potential.

Small-cap stocks, which have a market valuation between $300 million and $2 billion, are referred to as hidden gems in the stock market. They offer investors substantial growth potential. However, they are accompanied by higher volatility and risk compared to the larger and more established companies.

Pick the best stocks and maximize your portfolio:

Thus, to support investors’ search for the best small-cap stock, we have leveraged the TipRanks Stock Screener tool. These stocks have received a Strong buy rating from analysts and boast an Outperform Smart Score (i.e., 8, 9, or 10) on TipRanks, which points to their potential to beat the broader market. Further, analysts’ price targets reflect an upside potential of more than 60%.

Here are the five best small-cap stocks for investors to consider.

  • InMode (NASDAQ:INMD– This medical technology company specializes in aesthetic treatments and surgical technologies. Its price forecast of $48.80 implies a 117.9% upside. Also, the stock has a Smart Score of eight.
  • Fiverr International (NYSE:FVRR) – Fiverr is an online marketplace that connects businesses with freelancers offering various digital services and creative tasks. The stock’s average price target of $40.75 implies a consensus upside of 62.7% and carries a Smart Score of eight.
  • Arlo Technologies (NYSE:ARLO) – ARLO specializes in home security and video monitoring products, including wireless cameras and doorbells. The stock has an analyst consensus upside of 83.5% based on the average price target of $16. On TipRanks, ARLO earns a “Perfect 10” Smart Score.
  • Zentalis Pharmaceuticals (NASDAQ:ZNTL– The biopharmaceutical company focuses on developing targeted therapies for cancer treatments. ZNTL stock’s price forecast of $50.80 implies a 170.9% upside. It has a Smart Score of nine.
  • Nuvei Corp. (NASDAQ:NVEI) – Nuvei provides payment processing solutions for businesses of all sizes. The stock’s average price target of $31 implies a 104.6% upside potential. Also, its Smart Score of nine is encouraging. 

Disclosure

Related Articles
TipRanks Auto-Generated NewsdeskArlo Technologies Reports Strong Q3 2024 Performance
TheFlyArlo Technologies backs FY24 EPS view 35c-45c, consensus 41c
TheFlyArlo Technologies reports Q3 adjusted EPS 11c, consensus 10c
Go Ad-Free with Our App